Founder Guide

How to develop a saas pricing model?

SL
StartupLaby Editorial · 2026-04-27 · 3 min read

In medtech, “SaaS pricing” isn’t just a Stripe page decision—it’s a clinical workflow decision plus a hospital procurement decision. Your pricing model has to survive: (1) who benefits clinically, (2) who pays financially, (3) how risk is managed (regulatory, privacy, liability), and (4) how the product is actually deployed (EHR integration, IT review, security questionnaires).

Below is a step-by-step way to develop a SaaS pricing model for medtech (digital health, clinical decision support, imaging AI, remote monitoring platforms, device-connected software), with concrete options and how to validate them.

1) Start with the “who pays vs who uses” map

Most STEM founders price like a developer tool: per seat, monthly. In hospitals, the user and the payer are often different. Map three roles:

  • User: clinicians, nurses, techs, care coordinators.
  • Economic buyer: department chair, service line leader, CFO, population health, payer, or a value-based care entity.
  • Gatekeepers: IT/security, compliance/privacy, clinical governance, sometimes IRB if you’re doing research-like evaluation.

Then write a one-line “job” for each. Example: “Radiologist wants fewer false positives; imaging director wants faster turnaround; CFO wants reduced downstream cost; IT wants minimal integration burden.”

Why this matters for pricing: your price metric should align with the economic buyer’s budget logic (how they allocate spend), not the end user’s convenience.

2) Choose a value metric that matches clinical throughput and budget lines

A value metric is the unit you charge for (per user, per study, per bed, per site, etc.). In medtech, the best value metrics tend to correlate with either (a) clinical volume, (b) covered lives, or (c) operational capacity.

Common medtech SaaS value metrics (and when they work)

  • Per facility / per site (annual): Good when you sell to hospitals/IDNs and usage is broad. Easiest for procurement; harder to expand price with volume.
  • Per bed (annual): Works for inpatient workflow tools (sepsis surveillance, bed management). Aligns with capacity; can be contentious if outcomes aren’t clearly bed-linked.
  • Per clinician seat (monthly/annual): Works for narrow specialist tools (e.g., cardiology interpretation workflow). Risk: seat counts are political; adoption friction if you charge per user.
  • Per study / per scan / per case: Strong for imaging AI and diagnostics workflow. Aligns with volume and ROI per case; requires reliable counting and contract language.
  • Per patient monitored / per enrolled patient: Common in remote patient monitoring (RPM) and chronic care platforms. Aligns with program size; watch churn and eligibility rules.
  • % of savings / outcomes-based: Attractive in theory; difficult in practice due to attribution, baseline disputes, and long measurement cycles. Consider as an add-on, not your only model.

Rule of thumb: pick one primary value metric that is easy to measure, hard to game, and naturally scales with customer value. Add a secondary metric only if necessary (e.g., base platform fee + per study).

3) Build packaging around risk, workflow, and compliance (not just features)

Packaging is how you bundle capabilities into tiers (e.g., Basic/Pro/Enterprise). In medtech, tiers should map to deployment complexity and governance, not just “more buttons.”

A practical 3-tier structure for medtech SaaS

  1. Pilot / Limited Use: limited sites or volume, minimal integrations, standard reporting. Goal: prove clinical utility and workflow fit. Often time-boxed (e.g., 90–180 days) with clear success criteria.
  2. Clinical Production: includes required compliance artifacts (BAA for HIPAA in the US), audit logs, role-based access, uptime commitments, and operational support. This is where most hospital buyers expect you to be.
  3. Enterprise / IDN: multi-site governance, SSO (single sign-on), advanced security review support, integration options (EHR, PACS, HL7/FHIR), dedicated customer success, and possibly on-prem or private cloud options if required.

Instead of “Pro includes Feature X,” consider “Enterprise includes deployment assurances”: security questionnaire support, pen test summaries, data retention controls, and integration SLAs (service-level agreements—contracted performance commitments).

4) Anchor price to ROI, but quote in procurement-friendly terms

Hospitals rarely buy because your product is “cool.” They buy because it reduces cost, increases revenue, reduces risk, or improves quality metrics. You still need to translate that into a contract structure they can approve.

Medtech ROI sources you can price against

  • Time savings: fewer minutes per case, fewer clicks, faster triage. Convert to capacity (more cases/day) rather than “hours saved.”
  • Avoided adverse events: reduced complications, readmissions, missed diagnoses. Be careful with claims—your regulatory pathway (e.g., FDA 510(k), De Novo, or PMA) and labeling constrain what you can promise.
  • Revenue enablement: improved documentation, coding support, or program expansion. If reimbursement is involved (e.g., CPT codes), validate who captures the revenue (hospital vs physician group vs payer) and price accordingly.
  • Risk reduction: compliance, audit readiness, standardization. Often valued by leadership even if hard to quantify.

Procurement-friendly quoting: hospitals like annual subscriptions with predictable spend. Even if your internal logic is per-use, you can sell it as an annual commitment with a volume band (e.g., “up to X studies/year”) and overage pricing.

Don’t overfit to reimbursement early: If your product’s value depends on CPT reimbursement, confirm the billing pathway, who bills, and operational feasibility. Reimbursement varies by setting and payer; treat it as a validation track, not a pricing assumption.

5) Validate pricing with a structured discovery + pilot plan

Pricing is a hypothesis. Validate it the same way you validate clinical workflow: with controlled tests and clear endpoints.

A simple validation sequence (4 steps)

  1. Problem interviews (10–20): Ask how they budget today, what line item would fund this, and what alternatives cost (internal FTEs, incumbent vendors, doing nothing). Avoid asking “What would you pay?”—ask “What would you replace?”
  2. Packaging test (5–10): Show two or three tiers and ask which they’d choose and why. Listen for procurement blockers (SSO, BAA, integration, security review).
  3. Price sensitivity test (3–5): Use a bounded range: “If it were $A/year would it be a no-brainer? If it were $B/year would it be too expensive?” This is a practical version of price sensitivity without pretending it’s statistically perfect.
  4. Pilot with conversion clause: Run a paid pilot when possible. Include a pre-negotiated conversion option (e.g., “If success criteria are met, convert to annual at $X with Y terms”).

Medtech nuance: if your pilot involves prospective data collection or changes to clinical practice, you may encounter IRB review. Plan timelines accordingly and avoid pricing models that require immediate scale before governance clears.

6) Common medtech SaaS pricing traps (and safer alternatives)

  • Trap: Per-seat pricing that discourages adoption.
    Alternative: site license or department license with a reasonable user cap, or per-case pricing that aligns with usage.
  • Trap: “We’ll be outcomes-based” with no measurement infrastructure.
    Alternative: base subscription + optional performance bonus once you have baseline data and attribution agreement.
  • Trap: Underpricing to get logos, then getting stuck.
    Alternative: discount via scope (limited sites/volume) and term (pilot duration), not via permanent low unit price.
  • Trap: Ignoring integration and security costs.
    Alternative: separate one-time implementation fee or an “integration package” tier. Hospitals expect to pay for complex integration work.
  • Trap: Pricing that conflicts with your regulatory claims.
    Alternative: ensure marketing, contracts, and pricing promises match your intended FDA pathway (510(k), De Novo, PMA) and your cleared/authorized indications when applicable.

What to do next

  1. Write your value metric hypothesis: pick 1 primary metric (e.g., per study, per site, per patient monitored) and 1 backup; document why each matches the buyer’s budget.
  2. Draft a 3-tier package (Pilot / Production / Enterprise) where tiers differ by deployment assurances (BAA, SSO, audit logs, integration, SLAs), not just features.
  3. Run 10 buyer interviews focused on budget owner, budget line, and replacement cost; capture exact phrases and objections for your pricing page and sales deck.
  4. Design a paid pilot offer with clear success criteria and a pre-negotiated conversion price to avoid re-negotiating from scratch after proving value.
  5. Pressure-test procurement reality: ask one hospital IT/security contact what artifacts they require (SOC 2, pen test summary, data flow diagram) and reflect that in your Enterprise tier.

If you want feedback on your specific product, buyer, and proposed price metric, run a quick teardown using /roast or compare against incumbents in /Competitor_study.

Ready to actually build it?

Your idea, validated in 60 seconds.

Drop your startup idea. Get a brutal, honest AI verdict — score, red flags, and a shareable summary.

Roast my idea